title: Anti-inflammatory effect and mechanism of osthole in rats.
abstract: OBJECTIVE
  To investigate the anti-inflammatory effect and mechanism of osthole (Ost).
  
  
  METHODS
  Carrageenan -induced hind paw edema in rats were prepared. The nitric oxide synthase (NOS) activity was measured by NADPH -diaphoras stain assay, nitric oxide (NO) content by Griess diazotization assay, malondialdehyde (MDA) content by Thibabituric acid mehtods. And PG content was assaied by Uv -vis spectrophotometry with 278 nm after 0.5 mol/L KOH methanol reagent dissimilating.
  
  
  RESULTS
  The increase in NO2(-) observed 4h after carrageenan administration was inhibited by Ost from 524.4 +/- 58.7/micromol/L(-1) NO2(-) for carrageenan alone to 461.5 +/- 68. 8,353.8 +/- 111.0/micromol/L NO2(-) for, respectively, carrageenan administered in combination with 50 mg/kg or 100 mg/kg Ost. It suggested Ost suppress inflammatory responses on NO levels in a dose -dependent manner (P < 0.05). In the presence of Ost 100 mg/kg, NOS activities remained at near blank control levels. Meanwhile results showed reduced malondialdehyde production (MDA) in the presence of Ost, which is one of the byproducts of lipid peroxidation. Ost 50, 100 mg/kg markedly suppressed the generation of PG in inflamed paws.
  
  
  CONCLUSIONS
  Ost presents anti-inflammatory activities at the used models. The effects may be associated to a supression of content of PG, NO, MDA and cNOS activity by inhibition of calcium entry and elevating cGMP levels way.
authors.affiliation: Department of Pharmacology, Gannan Medical College, Ganzhou 341000.
authors.forename: Jianxin
authors.initials: J
authors.lastname: Liu
authors.forename: Wenping
authors.initials: W
authors.lastname: Zhang
authors.forename: Li
authors.initials: L
authors.lastname: Zhou
authors.forename: Xiurong
authors.initials: X
authors.lastname: Wang
authors.forename: Qishen
authors.initials: Q
authors.lastname: Lian
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002351:Carrageenan; D003374:Coumarins / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D005260:Female; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D010946:Plants, Medicinal / Q000737:chemistry*; D011453:Prostaglandins / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D003374:Coumarins; D011453:Prostaglandins; D009569:Nitric Oxide; D008315:Malondialdehyde; D002351:Carrageenan; D019001:Nitric Oxide Synthase; C046627:osthol